Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
312,579,912
-
Total 13F shares
-
301,421,729
-
Share change
-
+7,651,038
-
Total reported value
-
$3,479,958,222
-
Put/Call ratio
-
39%
-
Price per share
-
$11.55
-
Number of holders
-
215
-
Value change
-
+$96,361,873
-
Number of buys
-
87
-
Number of sells
-
115
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2021
As of 31 Dec 2021,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
215 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
301,421,729 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, Redmile Group, LLC, BlackRock Inc., Avoro Capital Advisors LLC, JPMORGAN CHASE & CO, MORGAN STANLEY, STATE STREET CORP, and Palo Alto Investors LP.
This page lists
215
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.